GCI Virtual Summit Thought Leader – Dr. Evan Lewis, Neurology Centre of Toronto

GCI Summit - Evan Lewis - Neurology Centre of Toronto - GCI Virtual Summit - Global Cannabis Intelligence

GCI Virtual Summit Thought Leader – Dr. Evan Lewis, Neurology Centre of Toronto

Evan participated as a thought leader at the GCI Virtual Summit 2020, joining 1000+ registered global leaders in both cannabis and psychedelics.

Check out his bio below:

Dr. Evan Lewis is a Pediatric Neurologist and Clinical Neurophysiologist with expertise in epilepsy. He is the founder & director of the Neurology Centre of Toronto (NCT). He is an Assistant Professor with the Department of Pediatrics at the Hospital for Sick Children and the University of Toronto.

Dr. Lewis attained his MD from the University of Ottawa, and trained as a Pediatric Neurologist at the Children’s Hospital of Eastern Ontario (CHEO).  He completed fellowships in both clinical neurophysiology and epilepsy at Nicklaus Children’s Hospital (formerly known as Miami Children’s Hospital) and the Hospital for Sick Children. Dr. Lewis held staff positions at SickKids and Holland Bloorview Kids Rehabilitation Hospital between 2016 and 2018.

Dr. Evan Lewis has significant clinical experience with medical cannabis in adults and children and is a member of the Canadian Consortium for the Investigation of Cannabinoids (CCIC), the Cannabinoid Research Initiative of Saskatchewan (CRIS) and the Canadian Childhood Cannabinoid Clinical Trials (C4T) group. He is a contributor and principal applicant on two major Canadian grants in clinical cannabis research and is a co-investigator for an international trial on cannabis in epilepsy to begin in 2021. Dr. Lewis is the Chief Medical Adviser for the Jamaican Medical Cannabis Corporation. He has spoken extensively on cannabis in neurologic disorders nationally and internationally.

Dr. Lewis is a Fellow of the Royal College of Physicians of Canada and was the Tariff Chair of the Neurology Section for the Ontario Medical Association from 2017 – 2019. He sits on the Editorial Board for the Journal of Child Neurology’s Resident/Fellow Section and is an ad-hoc reviewer for the Canadian Journal of Neurological Sciences and Paediatrics & Child Health.  His research and special interests include cannabinoids in the treatment of epilepsy and other neurological conditions, concussion, epilepsy, headache and teleneurology. Dr. Lewis is an advocate for the use of teleneurology to reach the underserved areas of Ontario, Canada.

If you are a leader operating in either the cannabis or psychedelics industries, check out the GCI Virtual Summit today! You can submit an application for a complimentary ticket for our 2021 Summit here.

You can also check out exclusive interviews with some of our GCI Virtual Summit thought leaders on the Content Hub.